Research Area

Our Research involves applying mass spectrometry-based technologies to perform metabolomics and lipidomic profiling of various cancer, cardiovascular and metabolic disorder to obtain biochemical insights into disease progression and to develop non-invasive metabolite signatures for prognostic and predictive biomarkers using non-invasive biofluids such as urine. This work entails the development of LC-MS/MS, GC-MS and LC-Q-TOF-MS/MS methods for the absolute and relative quantification of metabolites and lipids. Furthermore, lab also focused on identification and characterization of drug metabolites and drug degradation products by using LC-Q-TOF-MS/MS. Our interest includes biomonitoring of endocrine disruptors and other emerging environmental contaminants for characterizing human and wildlife exposure by using LC-MS/MS and GC/MS.